Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Boatman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The European Journal of Neuroscience|August 26, 2006
A thalamo-cortico-amygdala pathway mediates auditory fear conditioning in the intact brainJeffrey A Boatman, Jeansok J Kim
Biometrics|July 12, 2018
Estimating the causal effect of treatment regimes for organ transplantationJeffrey A Boatman, David M Vock
Statistics in Medicine|August 16, 2018
Efficiency and robustness of causal effect estimators when noncompliance is measured with errorJeffrey A Boatman, David M Vock, Joseph S Koopmeiners
Statistics in Medicine|June 22, 2021
Borrowing from supplemental sources to estimate causal effects from a primary data sourceJeffrey A Boatman, David M Vock, Joseph S Koopmeiners
Behavior Genetics|August 18, 2020
Modeling the Dependence Structure in Genome Wide Association Studies of Binary Phenotypes in Family DataSouvik Seal, Jeffrey A Boatman, Matt McGue, et al.
Biostatistics (Oxford, England)|June 13, 2017
Estimating causal effects from a randomized clinical trial when noncompliance is measured with errorJeffrey A Boatman, David M Vock, Joseph S Koopmeiners, et al.
Frontiers in Behavioral Neuroscience|July 16, 2010
Auditory Cortex is Important in the Extinction of Two Different Tone-Based Conditioned Fear Memories in RatsEun Young Song, Jeffrey A Boatman, Min Whan Jung, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) TrialJeffrey A Boatman, Jason V Baker, Sean Emery, et al.
Journal of Biopharmaceutical Statistics|March 6, 2023
Practical guidance on modeling choices for the virtual twins methodChuyu Deng, Jack M Wolf, David M Vock, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 24, 2019
The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for CigarettesJoseph S Koopmeiners, David M Vock, Jeffrey A Boatman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The European Journal of Neuroscience|August 26, 2006
A thalamo-cortico-amygdala pathway mediates auditory fear conditioning in the intact brainJeffrey A Boatman, Jeansok J Kim
Biometrics|July 12, 2018
Estimating the causal effect of treatment regimes for organ transplantationJeffrey A Boatman, David M Vock
Statistics in Medicine|August 16, 2018
Efficiency and robustness of causal effect estimators when noncompliance is measured with errorJeffrey A Boatman, David M Vock, Joseph S Koopmeiners
Statistics in Medicine|June 22, 2021
Borrowing from supplemental sources to estimate causal effects from a primary data sourceJeffrey A Boatman, David M Vock, Joseph S Koopmeiners
Behavior Genetics|August 18, 2020
Modeling the Dependence Structure in Genome Wide Association Studies of Binary Phenotypes in Family DataSouvik Seal, Jeffrey A Boatman, Matt McGue, et al.
Biostatistics (Oxford, England)|June 13, 2017
Estimating causal effects from a randomized clinical trial when noncompliance is measured with errorJeffrey A Boatman, David M Vock, Joseph S Koopmeiners, et al.
Frontiers in Behavioral Neuroscience|July 16, 2010
Auditory Cortex is Important in the Extinction of Two Different Tone-Based Conditioned Fear Memories in RatsEun Young Song, Jeffrey A Boatman, Min Whan Jung, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) TrialJeffrey A Boatman, Jason V Baker, Sean Emery, et al.
Journal of Biopharmaceutical Statistics|March 6, 2023
Practical guidance on modeling choices for the virtual twins methodChuyu Deng, Jack M Wolf, David M Vock, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 24, 2019
The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for CigarettesJoseph S Koopmeiners, David M Vock, Jeffrey A Boatman, et al.
Pageof 2